|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
AGE
|
AgeX Therapeutics, Inc.
|
US
|
AMEX
|
|
ANNX
|
Annexon, Inc.
|
US
|
NASDAQ
|
|
BCLI
|
Brainstorm Cell Therapeutics Inc.
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
DSGN
|
Design Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FREQ
|
Frequency Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
|
MITO
|
Stealth BioTherapeutics Corp.
|
US
|
NASDAQ
|
|
NRBO
|
NeuroBo Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VCNX
|
Vaccinex, Inc.
|
US
|
NASDAQ
|
|
ZBH
|
Zimmer Biomet Holdings, Inc.
|
US
|
NYSE
|
|
ACW
|
Actinogen Medical Ltd
|
AU
|
ASX
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|
|
CGNSF
|
Cognetivity Neurosciences Ltd
|
US
|
OTC
|
|
ERGO
|
Entia Biosciences, Inc
|
US
|
OTC
|
|
GEBHF
|
Genting Berhad
|
US
|
OTC
|
|
GEBHY
|
Genting Berhad Spons
|
US
|
OTC
|